Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013112
Filing Date
2022-06-17
Accepted
2022-06-17 17:06:03
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5642
  Complete submission text file 0001567619-22-013112.txt   6999
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Borellini Flavia (Reporting) CIK: 0001867426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 221024870